Voyageur Pharmaceuticals Ltd.
VYYRF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $20,094 | $22,122 | $23,834 | $390 |
| - Cash | $686 | $378 | $639 | $166 |
| + Debt | $29 | $40 | $40 | $40 |
| Enterprise Value | $19,437 | $21,784 | $23,235 | $265 |
| Revenue | $8 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$269 | $0 | $0 | $0 |
| % Margin | -3,346.4% | – | – | – |
| EBITDA | -$949 | -$544 | -$817 | -$458 |
| % Margin | -11,816.2% | – | – | – |
| Net Income | -$949 | -$544 | -$818 | -$459 |
| % Margin | -11,818.8% | – | – | – |
| EPS Diluted | -0.006 | -0.003 | -0.005 | -0.003 |
| % Growth | -67.6% | 35.8% | -60.6% | – |
| Operating Cash Flow | -$643 | -$261 | -$1,379 | $81 |
| Capital Expenditures | $0 | $0 | $0 | -$35 |
| Free Cash Flow | -$643 | -$261 | -$1,379 | $81 |